Check Palisade Bio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.6M
EPS (TTM)
-1.7233
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.39
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
-12.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
7531500.00%
Track how Palisade Bio Inc P/E has moved over time to understand its valuation trends.
Palisade Bio Inc in the last 5 years
Lowest (0.25x)
September 30, 2023
Industry (0.00x)
September 18, 2025
Today (-0.39x)
September 18, 2025
Highest (11.48x)
September 30, 2021
Today’s Price to Earnings Ratio: -0.39x
Compare market cap, revenue, PE, and other key metrics of Palisade Bio Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $5.6M | NA | -0.39 | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Palisade Bio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Palisade Bio Inc investment value today
Current value as on today
₹19,630
Returns
Returns from Palisade Bio Inc Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Palisade Bio Inc. Average target price of $8
Get share price movements and forecasts by analysts on Palisade Bio Inc.
What analysts predicted
92.63%UPSIDE
Target Price
$8
Current Price
$0.59
Analyzed by
8 Analysts
Target
$8.00
Palisade Bio Inc target price $8, a slight upside of 92.63% compared to current price of $0.59. According to 8 analysts rating.
Search interest for Palisade Bio Inc Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 203.3%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 154.0%
Price Dip
In the last 1 month, PALI stock has moved down by -27.9%
Organisation | Palisade Bio Inc |
Headquarters | 7750 El Camino Real, Carlsbad, CA, United States, 92009 |
CEO | Mr. J. D. Finley |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. J. D. Finley | CEO, CFO & Director |
Dr. Mitchell Lawrence Jones M.D., Ph.D. | COO & Chief Medical Officer |
Dr. Joerg Heyer Ph.D. | Head of Translational Science & Medicine |
Mr. Ryker Willie | Senior VP of Finance & Corporate Controller |
Palisade Bio Inc share price today is $0.59 as on . Palisade Bio Inc share today touched a day high of $0.59 and a low of $0.57.
Palisade Bio Inc share touched a 52 week high of $4.32 on and a 52 week low of $0.53 on . Palisade Bio Inc stock price today i.e. is trending at $0.59,which is 86.34% down from its 52 week high and 11.32% up from its 52 week low.
Palisade Bio Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Palisade Bio Inc (PALI) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Palisade Bio Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Palisade Bio Inc share’s latest price of $0.59 as on September 18, 2025 at 9:38 pm IST, you will get 16.9492 shares of Palisade Bio Inc. Learn more about
fractional shares .